Clinical Trial Update: Selpercatinib and Body Composition

View source ↗

Summary

A clinical trial evaluating the impact of selpercatinib on body composition in thyroid cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• RETEVMO (selpercatinib)

Snippet

Sponsor: University of Pisa | Conditions: Thyroid Cancer | Status: COMPLETED